2172 — MicroPort NeuroScientic Cashflow Statement
0.000.00%
- HK$5.95bn
- HK$4.93bn
- CNY761.76m
- 74
- 27
- 71
- 63
Annual cashflow statement for MicroPort NeuroScientic, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 51.4 | 31.9 | -4.33 | 162 | — |
Depreciation | |||||
Non-Cash Items | 4.22 | 40 | 135 | 55.5 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -20.9 | 53.8 | 36 | -120 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 47.2 | 157 | 224 | 154 | — |
Capital Expenditures | -34.1 | -58 | -47.9 | -42.2 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -38.9 | -129 | -297 | -191 | — |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -73 | -187 | -345 | -233 | — |
Financing Cash Flow Items | 148 | -115 | 79 | -0.93 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 432 | 201 | 330 | -33.3 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 403 | 168 | 235 | -107 | — |